67 related articles for article (PubMed ID: 8783793)
1. Herpes simplex virus-mediated activation of human immunodeficiency virus is inhibited by oligonucleoside methylphosphonates that target immediate-early mRNAs 1 and 3.
Feng CP; Kulka M; Smith C; Aurelian L
Antisense Nucleic Acid Drug Dev; 1996; 6(1):25-35. PubMed ID: 8783793
[TBL] [Abstract][Full Text] [Related]
2. Synergistic antiviral activities of oligonucleoside methylphosphonates complementary to herpes simplex virus type 1 immediate-early mRNAs 4, 5, and 1.
Kulka M; Smith CC; Levis J; Fishelevich R; Hunter JC; Cushman CD; Miller PS; Ts'o PO; Aurelian L
Antimicrob Agents Chemother; 1994 Apr; 38(4):675-80. PubMed ID: 8031030
[TBL] [Abstract][Full Text] [Related]
3. Activation of human immunodeficiency virus by herpesvirus infection: identification of a region within the long terminal repeat that responds to a trans-acting factor encoded by herpes simplex virus 1.
Mosca JD; Bednarik DP; Raj NB; Rosen CA; Sodroski JG; Haseltine WA; Hayward GS; Pitha PM
Proc Natl Acad Sci U S A; 1987 Nov; 84(21):7408-12. PubMed ID: 2823260
[TBL] [Abstract][Full Text] [Related]
4. NF-kappa B-binding proteins induced by HSV-1 infection of U937 cells are not involved in activation of human immunodeficiency virus.
Feng CP; Kulka M; Aurelian L
Virology; 1993 Feb; 192(2):491-500. PubMed ID: 8380662
[TBL] [Abstract][Full Text] [Related]
5. Mapping of intracellular localization domains and evidence for colocalization interactions between the IE110 and IE175 nuclear transactivator proteins of herpes simplex virus.
Mullen MA; Ciufo DM; Hayward GS
J Virol; 1994 May; 68(5):3250-66. PubMed ID: 8151787
[TBL] [Abstract][Full Text] [Related]
6. Herpes simplex virus type 2 growth and latency reactivation by cocultivation are inhibited with antisense oligonucleotides complementary to the translation initiation site of the large subunit of ribonucleotide reductase (RR1).
Aurelian L; Smith CC
Antisense Nucleic Acid Drug Dev; 2000 Apr; 10(2):77-85. PubMed ID: 10805158
[TBL] [Abstract][Full Text] [Related]
7. The GGTCA palindrome and cognate cellular factors in trans-regulation of human immunodeficiency virus long terminal repeat by herpes simplex virus.
Feng CP; Kulka M; Aurelian L
J Gen Virol; 1993 Apr; 74 ( Pt 4)():715-23. PubMed ID: 8385697
[TBL] [Abstract][Full Text] [Related]
8. A recombinant HIV provirus is synergistically activated by the HIV Tat protein and the HSV IE1 protein but not by the HSV IE3 protein.
Chapman CJ; Harris JD; Collins MK; Latchman DS
AIDS; 1991 Aug; 5(8):945-50. PubMed ID: 1777175
[TBL] [Abstract][Full Text] [Related]
9. Direct correlation between a negative autoregulatory response element at the cap site of the herpes simplex virus type 1 IE175 (alpha 4) promoter and a specific binding site for the IE175 (ICP4) protein.
Roberts MS; Boundy A; O'Hare P; Pizzorno MC; Ciufo DM; Hayward GS
J Virol; 1988 Nov; 62(11):4307-20. PubMed ID: 2845144
[TBL] [Abstract][Full Text] [Related]
10. Identification of a dimerization domain in the C-terminal segment of the IE110 transactivator protein from herpes simplex virus.
Ciufo DM; Mullen MA; Hayward GS
J Virol; 1994 May; 68(5):3267-82. PubMed ID: 8151788
[TBL] [Abstract][Full Text] [Related]
11. Differential activation of hybrid genes containing herpes simplex virus immediate-early or delayed-early promoters after superinfection of stable DNA-transfected cell lines.
Mosca JD; Reyes GR; Pitha PM; Hayward GS
J Virol; 1985 Dec; 56(3):867-78. PubMed ID: 2415716
[TBL] [Abstract][Full Text] [Related]
12. Activation of the human immunodeficiency virus by herpes simplex virus type 1.
Ostrove JM; Leonard J; Weck KE; Rabson AB; Gendelman HE
J Virol; 1987 Dec; 61(12):3726-32. PubMed ID: 2446005
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of viral growth by antisense oligonucleotides directed against the IE110 and the UL30 mRNA of herpes simplex virus type-1.
Peyman A; Helsberg M; Kretzschmar G; Mag M; Grabley S; Uhlmann E
Biol Chem Hoppe Seyler; 1995 Mar; 376(3):195-8. PubMed ID: 7612196
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of colocalization interactions between the IE110, IE175, and IE63 transactivator proteins of herpes simplex virus within subcellular punctate structures.
Mullen MA; Gerstberger S; Ciufo DM; Mosca JD; Hayward GS
J Virol; 1995 Jan; 69(1):476-91. PubMed ID: 7983744
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation of the HIV-1 LTR by specific NF-kappa B subunits in HSV-1-infected cells.
Schafer SL; Hiscott J; Pitha PM
Virology; 1996 Oct; 224(1):214-23. PubMed ID: 8862416
[TBL] [Abstract][Full Text] [Related]
16. Transcription of the human immunodeficiency virus type 1 (HIV-1) promoter in central nervous system cells: effect of YB-1 on expression of the HIV-1 long terminal repeat.
Sawaya BE; Khalili K; Amini S
J Gen Virol; 1998 Feb; 79 ( Pt 2)():239-46. PubMed ID: 9472608
[TBL] [Abstract][Full Text] [Related]
17. Antiviral effect of oligo(nucleoside methylphosphonates) complementary to the herpes simplex virus type 1 immediate early mRNAs 4 and 5.
Kulka M; Wachsman M; Miura S; Fishelevich R; Miller PS; Ts'o PO; Aurelian L
Antiviral Res; 1993 Feb; 20(2):115-30. PubMed ID: 8384823
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of human immunodeficiency virus by using an oligonucleoside methylphosphonate targeted to the tat-3 gene.
Zaia JA; Rossi JJ; Murakawa GJ; Spallone PA; Stephens DA; Kaplan BE; Eritja R; Wallace RB; Cantin EM
J Virol; 1988 Oct; 62(10):3914-7. PubMed ID: 2458490
[TBL] [Abstract][Full Text] [Related]
19. Differential effect of tumor necrosis factor-alpha and herpes simplex virus type 1 on the Tat-targeted inhibition of human immunodeficiency virus type 1 replication.
Popik W; Pitha PM
Virology; 1994 Aug; 202(2):521-9. PubMed ID: 8030218
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the IE110 gene of herpes simplex virus type 1.
Perry LJ; Rixon FJ; Everett RD; Frame MC; McGeoch DJ
J Gen Virol; 1986 Nov; 67 ( Pt 11)():2365-80. PubMed ID: 3023529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
